Skip to main content
Erschienen in: Wiener klinische Wochenschrift 7-8/2012

01.04.2012 | original article

Effects ofHelicobacter pylori eradication on proteinuria: a prospective study

verfasst von: Timucin Aydogan, Turgay Ulas, Yusuf Selcoki, Rabia Alkan, Omer Caglar Yılmaz, Kadir Serkan Yalcın, Osman Inan, Mehmet Sinan Dal, Cansel Turkay

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 7-8/2012

Einloggen, um Zugang zu erhalten

Summary

Background

Helicobacter pylori is one of the most common bacterial infections, seen in humans worldwide and its possible relationship to different diseases is a focus of attention nowadays. The aim of this study was to analyse the effects ofH. Pylori eradication on proteinuria.

Methods

Ninety-nine patients suffering from dyspeptic complaints were recruited in this prospective study. The patients were divided into two groups according to the presence ofH. pylori infection. Thus, a total of 67 H. pylori positive and 32 H. pylori negative patients were studied. TheH. pylori positive patients’ group was divided into two groups according to response toH. pylori eradication treatment. A total of three groups were formed, viz; group 1 comprises of patients who areH. pylori positive and responds positively toH. pylori eradication therapy, group 2 comprises of patients who areH. pylori positive and responds negatively toH. pylori eradication therapy and group 3 is the control group and comprises of patients that areH. pylori negative. Urine samples to obtain the protein/creatinine ratio were collected initially and at the end of the study from all patients.

Results

Mean difference levels (pre- and post-treatment difference) of urine protein/creatinine ratio was 0.055 ± 0.13 in group 1. The ratio was − 0.0007 ± 0.0067 in group 2 and − 0.0022 ± 0.008 in group 3. A statistically significant difference was found in group 1 compared to the other groups in terms of mean difference levels of protein/creatinine ratios (p < 0.001).

Conclusion

As a result of our study, treatment ofH. pylori eradication significantly reduced the proteinuria within the normal limits.
Literatur
1.
Zurück zum Zitat Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med. 2007;101(2):203–9.PubMedCrossRef Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med. 2007;101(2):203–9.PubMedCrossRef
2.
Zurück zum Zitat Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45(8):1219–22.PubMedCrossRef Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45(8):1219–22.PubMedCrossRef
3.
Zurück zum Zitat Franceschi F, Gasbarrini A. Helicobacter pylori and extra-gastric diseases. Best Pract Res Clin Gastroenterol. 2007;21(2):325–34.PubMedCrossRef Franceschi F, Gasbarrini A. Helicobacter pylori and extra-gastric diseases. Best Pract Res Clin Gastroenterol. 2007;21(2):325–34.PubMedCrossRef
4.
Zurück zum Zitat Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull. 1998;54(1):139–50.PubMedCrossRef Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull. 1998;54(1):139–50.PubMedCrossRef
5.
Zurück zum Zitat Konturek SJ, Konturek PC, Pieniazek P, Bielański W. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. J Physiol Pharmacol. 1999;50(5):683–94.PubMed Konturek SJ, Konturek PC, Pieniazek P, Bielański W. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. J Physiol Pharmacol. 1999;50(5):683–94.PubMed
6.
Zurück zum Zitat Bohr UR, Annibale B, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection—other Helicobacters. Helicobacter. 2007;12(Suppl 1):45–53.PubMedCrossRef Bohr UR, Annibale B, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection—other Helicobacters. Helicobacter. 2007;12(Suppl 1):45–53.PubMedCrossRef
7.
Zurück zum Zitat Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: Helicobacter pylori infection. Med Hypotheses. 2007;69(3):709–10.PubMedCrossRef Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: Helicobacter pylori infection. Med Hypotheses. 2007;69(3):709–10.PubMedCrossRef
8.
Zurück zum Zitat Nagashima R, Maeda K, Yuda F, Kudo K, Saitoh M, Takahashi T. Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy. Virchows Arch. 1997;431(4):235–9.PubMedCrossRef Nagashima R, Maeda K, Yuda F, Kudo K, Saitoh M, Takahashi T. Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy. Virchows Arch. 1997;431(4):235–9.PubMedCrossRef
9.
Zurück zum Zitat Moriyama T, Kaneko T, Fujii M, Tsubakihara Y, Kawano S, Imai E. High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy. Aliment Pharmacol Ther. 2006;2(1):189–93CrossRef Moriyama T, Kaneko T, Fujii M, Tsubakihara Y, Kawano S, Imai E. High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy. Aliment Pharmacol Ther. 2006;2(1):189–93CrossRef
10.
Zurück zum Zitat Sugimoto T, Furukawa T, Maeda T, Somura M, Uzu T, Kashiwagi A. Marked reduction of proteinuria after eradication of gastric Helicobacter pylori infection in a patient with membranous nephropathy: coincidental or associated? Intern Med. 2007;46(17):1483–4.PubMedCrossRef Sugimoto T, Furukawa T, Maeda T, Somura M, Uzu T, Kashiwagi A. Marked reduction of proteinuria after eradication of gastric Helicobacter pylori infection in a patient with membranous nephropathy: coincidental or associated? Intern Med. 2007;46(17):1483–4.PubMedCrossRef
11.
Zurück zum Zitat Hirschl AM. Helicobacter pylori: pathogens, pathomechanisms and epidemiology. Wien Klin Wochenschr. 1994;106(17):538–42.PubMed Hirschl AM. Helicobacter pylori: pathogens, pathomechanisms and epidemiology. Wien Klin Wochenschr. 1994;106(17):538–42.PubMed
12.
Zurück zum Zitat Kanbay M, Kasapoglu B, Turgut F, Uz E, Bavbek N, Akcay A. Helicobacter pylori: a major risk factor for endothelial dysfunction? Med Hypotheses. 2007;69(1):227–8.PubMedCrossRef Kanbay M, Kasapoglu B, Turgut F, Uz E, Bavbek N, Akcay A. Helicobacter pylori: a major risk factor for endothelial dysfunction? Med Hypotheses. 2007;69(1):227–8.PubMedCrossRef
Metadaten
Titel
Effects ofHelicobacter pylori eradication on proteinuria: a prospective study
verfasst von
Timucin Aydogan
Turgay Ulas
Yusuf Selcoki
Rabia Alkan
Omer Caglar Yılmaz
Kadir Serkan Yalcın
Osman Inan
Mehmet Sinan Dal
Cansel Turkay
Publikationsdatum
01.04.2012
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 7-8/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0150-0

Weitere Artikel der Ausgabe 7-8/2012

Wiener klinische Wochenschrift 7-8/2012 Zur Ausgabe